Avantor is a medical instruments & supplies business based in the US. Avantor shares (AVTR) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $20.14 – a decrease of 4.78% over the previous week. Avantor employs 14,500 staff and has a trailing 12-month revenue of around $6.8 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $20.14 |
|---|---|
| 52-week range | $19.23 - $28.00 |
| 50-day moving average | $24.70 |
| 200-day moving average | $24.28 |
| Wall St. target price | $27.31 |
| PE ratio | 47 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.45 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $19.72 from 2024-11-19
| 1 week (2024-11-14) | -6.76% |
|---|---|
| 1 month (2024-10-21) | -19.48% |
| 3 months (2024-08-21) | -22.45% |
| 6 months (2024-05-21) | -20.80% |
| 1 year (2023-11-21) | -0.40% |
|---|---|
| 2 years (2022-11-21) | -4.83% |
| 3 years (2021-11-19) | 39.66 |
| 5 years (2019-11-21) | 20.24% |
Valuing Avantor stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avantor's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avantor's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, Avantor shares trade at around 47x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Avantor's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 billion.
The EBITDA is a measure of a Avantor's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $6.8 billion |
|---|---|
| Operating margin TTM | 7.31% |
| Gross profit TTM | $2.6 billion |
| Return on assets TTM | 3.27% |
| Return on equity TTM | 5.81% |
| Profit margin | 4.54% |
| Book value | $8.16 |
| Market Capitalization | $14.4 billion |
TTM: trailing 12 months
We're not expecting Avantor to pay a dividend over the next 12 months.
Over the last 12 months, Avantor's shares have ranged in value from as little as $19.23 up to $28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Avantor's is 1.348. This would suggest that Avantor's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.